Cancer treatments have recently shifted from broad-spectrum cytotoxic therapies to more
focused treatments, maximizing anticancerous activity while reducing toxicity to healthy …

The proliferation of targeted anticancer agents over the last two decades has revolutionized
cancer treatment and improved survival in many previously refractory malignancies …

Objective. To analyse the worldwide occurrence of sicca/Sjögren's (SS) syndrome
associated with the use of immune checkpoint inhibitors (ICI) in patients with cancer …

A properly functioning cornea is critical to clear vision and healthy eyes. As the most anterior
portion of the eye, it plays an essential role in refracting light onto the retina and as an …

Ovarian cancer (OC) is the most lethal gynecological malignancy and is responsible for most
gynecological cancer deaths. Apart from conventional surgery, chemotherapy, and …

Newer anticancer drugs have revolutionized cancer treatment in the last decade, but
conventional chemotherapy still occupies a central position in many cancers, with …

Antibody-drug conjugates (ADCs) are a growing class of chemotherapeutic agents for the
purpose of treating cancers that often have relapsed or failed first-and second-line …

Purpose Ado-trastuzumab emtansine (T-DM1/Kadcyla®; Genentech) is an antibody-drug
conjugate used in the treatment of human epidermal growth factor receptor-2-positive …

Simple Summary Anticancer drugs can determine alterations in the ocular surface system as
side effects that can be referred to by patients as ocular discomfort symptoms and …

Purpose: To report a case of atypical corneal lesions presumably induced by trastuzumab
emtansine, an antibody–drug conjugate that is designed to selectively deliver cytotoxic …